Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Genomics, |
RCV000002199 | SCV004046877 | pathogenic | Pyruvate dehydrogenase E3-binding protein deficiency | 2023-10-23 | criteria provided, single submitter | clinical testing | This homozygous termination (stop-gain) [PVS1] variant is identified in a 7 year male with neonatal seizures, polydactyly and later developed severe ID with microcephaly. Metabolic acidosis and increased lactate. MRI brain: periventricular leukomalacia. This nucleotide change is absent in gnomAD database [PM2]. Insilico prediction [MutationTaster] predicts a deleterious nature of this variant. A clinvar entry for this variant is available [Variation ID: 2881] with an interpretation of “Pathogenic” [PP5]. Based on the clinical correlation and available evidence, this variant is classified as "Pathogenic" |
Institute of Human Genetics, |
RCV000002199 | SCV004244362 | pathogenic | Pyruvate dehydrogenase E3-binding protein deficiency | 2024-01-23 | criteria provided, single submitter | clinical testing | Criteria applied: PVS1,PM3,PM2_SUP |
OMIM | RCV000002199 | SCV000022357 | pathogenic | Pyruvate dehydrogenase E3-binding protein deficiency | 2007-02-01 | no assertion criteria provided | literature only |